Filter by:

First Line of Defense

Last fall’s announcement that virulent antibiotic-resistant staph infections had killed almost 19,000 patients in American hospitals and nursing homes in 2005 didn’t surprise George Allen. With colleagues David Bearden and Mark Christensen, the assistant professor in the OSU College of Pharmacy studies antibiotic effectiveness. He focuses on a class of broad-spectrum antibiotics known as fluoroquinolones, […]